Cartesian Therapeutics paid its 5 named executives $12.4M in total in FY2025 (Dec). CEO Carsten Brunn, Ph.D. was paid $4.3M of that.
Pay$100 in the stock at the end of FY22 → $21
Pay of each named executive
Carsten Brunn, Ph.D.President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Metin Kurtoglu, M.D., Ph.D.Former Chief Technology Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Christopher Jewell, Ph.D.Former Chief Scientific Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Blaine DavisChief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Milos Miljkovic, M.D.Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 11 peers with pay on file was $4.2M. The CEO of Cartesian Therapeutics was paid $4.3M, 3% above the median.
- 1Cogent Biosciences
- 2MeiraGTx Holdings
- 3Corvus Pharmaceuticals
- 4Anaptysbio
- 5Savara
- 6Cartesian TherapeuticsThis company
- 7Regenxbio
- 8Replimune Group
- 9Annexon
- 10Rocket Pharmaceuticals
- 11Lineage Cell Therapeutics
- 124D Molecular Therapeutics
- 13AlectorNot disclosed
- 14Allogene TherapeuticsNot disclosed
- 15Cabaletta BioNot disclosed
- 16Candel TherapeuticsNot disclosed
- 17MacrogenicsNot disclosed
- 18RezoluteNot disclosed
- 19Viridian TherapeuticsNot disclosed
- 20Vor BiopharmaNot disclosed
'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-2'%20d='M18.156,40.577.011,29.356l0-18.125L18.147,0'%20transform='translate(-0.004%20-0.001)'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-3'%20d='M35.133,14.327H26.354l4.389-7.163L35.127,0l4.395,7.164,4.389,7.163Z'%20transform='translate(-16.985)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-4'%20d='M51.052,93.782l0-8.211,18.178-3.019Z'%20transform='translate(-32.9%20-53.206)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-5'%20d='M69.213,11.223l-9.4,3.1L51.035,0Z'%20transform='translate(-32.892%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-6'%20d='M.01,11.23l9.387,3.1L18.148,0Z'%20transform='translate(-0.006%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-7'%20d='M75.741,34.672l9.4-3.1,0,18.125Z'%20transform='translate(-48.815%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-8'%20d='M9.406,34.672l-9.4-3.1,0,18.125Z'%20transform='translate(-0.004%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-9'%20d='M18.15,93.786l.016-8.209L0,82.56Z'%20transform='translate(0%20-53.21)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-10'%20d='M59.826,40.3,51.047,58.34l18.178-3.019Z'%20transform='translate(-32.9%20-25.974)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-11'%20d='M9.393,40.3l8.773,18.041L0,55.321Z'%20transform='translate(0%20-25.971)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-12'%20d='M35.174,40.3H26.418l4.367,9.019,4.4,9.027,4.373-9.027,4.389-9.02Z'%20transform='translate(-17.026%20-25.974)'%20fill='%238fd4e2'/%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.